Terug
Dagbereik
€ 15,01
€ 16,10
52-Weeksbereik
€ 7,76
€ 71,50
Volume
1.766.376
50D / 200D Gem.
€ 20,69
/
€ 25,16
Vorige Slotkoers
€ 15,92
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4,7 | 0,3 |
| P/B | 4,7 | 2,9 |
| ROE % | -207,1 | 3,7 |
| Net Margin % | -1236,0 | 3,8 |
| Rev Growth 5Y % | -58,1 | 10,0 |
| D/E | 2,7 | 0,2 |
Koersdoel Analisten
Hold
€ 41,80
+175.4%
Low: € 11,00
High: € 95,00
Forward WPA
-€ 3,49
Omzet Sch.
32 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,52
€ 0,37 – € 3,90
|
580 M | 5 |
| FY2029 |
-€ 0,56
-€ 1,44 – -€ 0,14
|
370 M | 2 |
| FY2028 |
-€ 2,61
-€ 4,42 – € 1,21
|
180 M | 7 |
Belangrijkste Punten
Revenue declined -58,13% annually over 5 years
Debt/Equity of 2,70 — high leverage
Negative free cash flow of -177,96M
PEG of 0,23 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 17,49%
Capital efficient — spends only 2,73% of revenue on capex
Groei
Revenue Growth (5Y)
-58,13%
Revenue (1Y)-40,64%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-207,10%
ROIC-18,91%
Net Margin-1236,00%
Op. Margin-1152,13%
Veiligheid
Debt / Equity
2,70
Current Ratio10,43
Interest Coverage-2,99
Waardering
P/E Ratio
-4,70
P/B Ratio4,70
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -40,64% | Revenue Growth (3Y) | 0,80% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -58,13% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 16,10M | Net Income (TTM) | -198,97M |
| ROE | -207,10% | ROA | -24,12% |
| Gross Margin | -2,16% | Operating Margin | -1152,13% |
| Net Margin | -1236,00% | Free Cash Flow (TTM) | -177,96M |
| ROIC | -18,91% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,70 | Current Ratio | 10,43 |
| Interest Coverage | -2,99 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,70 | P/B Ratio | 4,70 |
| P/S Ratio | 58,09 | PEG Ratio | 0,23 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 935,15M | Enterprise Value | 1,39B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 16,10M | 27,12M | 15,84M | 106,48M | 524,00M |
| Net Income | -198,97M | -239,56M | -308,48M | -126,79M | 329,59M |
| EPS (Diluted) | -3,46 | -4,92 | -6,47 | -2,71 | 7,04 |
| Gross Profit | -347.000,0 | 8,79M | 2,22M | 103,14M | 499,03M |
| Operating Income | -185,47M | -184,29M | -282,87M | -143,16M | 310,62M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 824,91M | 556,54M | 831,69M | 704,96M | 809,18M |
| Total Liabilities | 626,01M | 563,29M | 624,02M | 228,96M | 213,40M |
| Shareholders' Equity | 198,90M | -6,75M | 207,67M | 476,01M | 595,78M |
| Total Debt | 536,59M | 66,06M | 138,41M | 142,89M | 135,72M |
| Cash & Equivalents | 80,24M | 158,93M | 241,36M | 228,01M | 556,26M |
| Current Assets | 655,99M | 390,29M | 651,85M | 476,77M | 628,24M |
| Current Liabilities | 62,92M | 40,05M | 73,68M | 75,92M | 36,76M |